POLYPHOR – INNOVATION IN DRUG DISCOVERY
Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs.
These macrocycles represent a new drug class complementary to the classical small molecules and large biopharmaceuticals.
Our proprietary and unique technologies are broadly applicable to a wide array of biological targets and disease areas and provide innovative treatment options.
We leverage our technologies to develop our own product portfolio and to pursue licensing and collaboration opportunities.
October 23-26, 2016 – Grand Challenges Annual Meeting: meet Dr. Glenn Dale on October 26.
November 14-15, 2016 – Superbugs & Superdrugs: meet Dr. Daniel Obrecht on November 14.
November 14-17, 2016 – EuroPeptides Congress: meet Prof. John Robinson/ Dr. Steffen Weinbrenner on November 14/15.
Tel. +41 61 567 16 00
Fax +41 61 567 16 01
Last modified: 31.10.2016